Aarti Drugs
BSE 524348
4 stories, newest first.
- Crisil ESG Ratings assigns 'Crisil ESG 61' (Strong) rating based on FY 2025-26 data
- Authorized persons for determining materiality and making disclosures to exchanges named from October 1, 2026
- Chairman, MD & CEO Prakash M. Patil retires early; Adhish P. Patil promoted to MD, steps down as CFO
- Shareholder presentation shared at 41st AGM covering FY 2025-26 milestones
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.